Drug
Encorafenib Formulation
Encorafenib Formulation: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Encorafenib capsule formulation (CAP) NCT05446142 | Phase 1 | Healthy |
Latest
No recent events.
Follow Encorafenib Formulation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.